Publicaciones en las que colabora con Gad Rennert (31)

2024

  1. Identification of genetically predicted DNA methylation markers associated with non–small cell lung cancer risk among 34,964 cases and 448,579 controls

    Cancer, Vol. 130, Núm. 6, pp. 913-926

  2. Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies

    Cancer Epidemiology Biomarkers and Prevention, Vol. 33, Núm. 3, pp. 389-399

  3. On the informative value of community-based indoor radon values in relation to lung cancer

    Cancer Medicine, Vol. 13, Núm. 16

2023

  1. Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis

    Journal of Thoracic Oncology, Vol. 18, Núm. 8, pp. 1003-1016

2022

  1. Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer

    Nature Genetics, Vol. 54, Núm. 8, pp. 1167-1177

  2. Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk

    Human molecular genetics, Vol. 31, Núm. 16, pp. 2831-2843

2021

  1. Assessing lung cancer absolute risk trajectory based on a polygenic risk model

    Cancer Research, Vol. 81, Núm. 6, pp. 1607-1615

  2. Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization

    International Journal of Cancer, Vol. 148, Núm. 5, pp. 1077-1086

  3. Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma

    Frontiers of Medicine, Vol. 15, Núm. 2, pp. 275-291

  4. Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer

    Genetic Epidemiology, Vol. 45, Núm. 1, pp. 99-114

2020

  1. Association Analysis of Driver Gene-Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 29, Núm. 7, pp. 1423-1429

  2. Genome-wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk

    International Journal of Cancer, Vol. 146, Núm. 10, pp. 2855-2864

  3. Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility

    Nature Communications, Vol. 11, Núm. 1

  4. Protein-altering germline mutations implicate novel genes related to lung cancer development

    Nature Communications, Vol. 11, Núm. 1

  5. Transcriptome-wide association study reveals candidate causal genes for lung cancer

    International Journal of Cancer, Vol. 146, Núm. 7, pp. 1862-1878

2019

  1. Alcohol consumption and lung cancer risk: A pooled analysis from the International Lung Cancer Consortium and the SYNERGY study

    Cancer Epidemiology, Vol. 58, pp. 25-32

  2. Elevated platelet count appears to be causally associated with increased risk of lung cancer: A mendelian randomization analysis

    Cancer Epidemiology Biomarkers and Prevention, Vol. 28, Núm. 5, pp. 935-942

  3. Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development

    Oncotarget, Vol. 10, Núm. 19, pp. 1760-1774

  4. Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region

    Journal of Thoracic Oncology, Vol. 14, Núm. 8, pp. 1360-1369

  5. Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers

    International Journal of Epidemiology, Vol. 48, Núm. 3, pp. 751-766